Eli Lilly CEO David Ricks on Q2 earnings, obesity pill late-stage trial results

CNBC’s Angelica Peebles and Eli Lilly chairman and CEO David Ricks join 'Squawk Box' to discuss the company's quarterly earnings results, late-stage trial data on its experimental obesity pill orforglipron, drug pipeline outlook, and more.